{"database":"GNPS","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://massive-ftp.ucsd.edu/v01/MSV000080142/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":{"citationCount":0,"reanalysisCount":0,"viewCount":0,"searchCount":0},"additional":{"omics_type":["Metabolomics"],"submitter":["James McKerrow"],"instrument_platform":["Q-Exactive"],"species":["Trypanosoma Cruzi (ncbitaxon:5693)","Mus Musculus (ncbitaxon:10090)"],"full_dataset_link":["https://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=275970f259a744969ad7ba4c3780b1c3"],"sample_protocol":[""],"repository":["GNPS"],"file_size":["1,622"],"ptm_modification":["none"],"data_protocol":[""],"citation_count":["0"],"additional_accession":[]},"is_claimable":false,"name":"GNPS - MSKCC Target ID T. cruzi","description":"Infected C2C12 myocytes and free T. cruzi parasites were treated with varying doses of an experimental compound from MKSCC for different timepoints, with the goal of identifying metabolome changes caused by the drug treatment.","dates":{},"accession":"MSV000080142","cross_references":{}}